Michael Berelowitz Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Berelowitz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Berelowitz. Michael Berelowitz is Director in ORAMED PHARMACEUTICALS INC. ($IGVL) and Director in Recro Pharma, Inc. ($REPH).
Michael Berelowitz in Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Berelowitz: Director
Holdings: 76,546 shares
Current Value: $616,195
Latest Transaction: Apr 22 2021
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Berelowitz in Recro Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 26,923 | 0 | 76,546 | 49.6 K to 76.5 K (+54.26 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 8,363 | 0 | 49,623 | 41.3 K to 49.6 K (+20.27 %) |
| Dec 09 2019 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 13,848 | 0 | 41,260 | 27.4 K to 41.3 K (+50.52 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 7,955 | 0 | 27,412 | 19.5 K to 27.4 K (+40.89 %) |
| May 08 2018 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
| Mar 13 2018 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | M | 2.47 | 7,500 | 18,525 | 14,500 | |
| Mar 13 2018 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Sell | S | 10.45 | 7,500 | 78,347 | 0 | 7.5 K to 0 (-100.00 %) |
| Mar 13 2018 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Buy | M | 2.47 | 7,500 | 18,525 | 7,500 | 0 to 7.5 K |
| May 16 2017 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 0.00 | 13,274 | 0 | 13,274 | |
| Dec 18 2015 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 8.41 | 10,000 | 84,100 | 10,000 |
Page: 1